Chester Mark Robachinski, M.D.
Opted out of Medicare from February 2016 to February 2028. Psychiatry & Neurology, Psychiatry (M.D.) in Seattle, Washington, licensed in WA, with an NPI issued in April 2006. Part D covered 796 prescriptions written in 2024, 91% of them generic. Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) was the largest of 11 companies reporting payments in 2025, $271,758 in all, mostly speaking and faculty fees.
Overview
| NPI | 1285697573 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 8, 2006 |
| Last updated in NPPES | Jul 13, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Psychiatry & Neurology, Psychiatry Primary | 2084P0800X | MD00027330 | WA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Feb 1, 2016 – Feb 1, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 796 · 1,033 30-day fills |
|---|---|
| Patients | 41 |
| Total drug cost | $157,732 |
| Generic share | 91% of claims |
Industry payments (Open Payments)
- 2025$271,758 · 387 payments from 11 companies
- 2024$206,527 · 292 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $71,864 | 90 |
| Vanda Pharmaceuticals Inc. | $65,360 | 96 |
| Janssen Pharmaceuticals, Inc | $64,019 | 81 |
| Axsome Therapeutics, Inc. | $40,408 | 52 |
| Alkermes, Inc. | $17,704 | 31 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$169,016 · 54 payments
- Travel and Lodging$35,272 · 147 payments
- Honoraria$34,100 · 9 payments
- Consulting Fee$23,798 · 9 payments
- Food and Beverage$9,572 · 168 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Psychiatry & Neurology, Psychiatry providers in Seattle
- 1992652283
- 1144789249
- 1083526115
- 1639685241
- 1588591820
- 1093659708
- 1730015249
- 1265389555
- 1275316358
- 1427901636
- 1740312784
- 1831620541
All Psychiatry & Neurology, Psychiatry providers in Washington →